XML 65 R43.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Employee Benefits and Stock Compensation (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract] |
Schedule of Share-Based Compensation | The impact of share-based compensation on the Company’s financial results is presented below:
|  | For the Year Ended December 31,
(In thousands) |  | 2024 |  | 2023 |  | 2022
Share-based compensation expense 1 |  | $ | 13,744 |  |  | $ | 13,440 |  |  | $ | 11,155 |
Income tax benefit |  | $ | (3,483) |  |  | $ | (3,406) |  |  | $ | (2,827) |
1 Excludes $10.3 million in 2023 and $10.4 million in 2022 associated with replacement awards granted in bank acquisitions.
Schedule of Unrecognized Compensation Cost, Nonvested Awards | The total unrecognized compensation cost and the weighted-average period over which unrecognized compensation cost is expected to be recognized related to non-vested share-based compensation arrangements at December 31, 2024 is presented below:
(In thousands) |  | Unrecognized Compensation Cost |  | Weighted-Average Period Remaining (Years)
Restricted stock awards |  | $ | 16,339 |  |  | 1.80
Restricted stock units |  | 6,829 |  |  | 2.21
Total |  | $ | 23,168 |  |  | 1.92
Schedule of Nonvested Share Activity | A summary of the status of the Company’s non-vested RSAs as of December 31, 2024, and changes during the year then ended, is presented below:
|  | Restricted Award Shares |  | Weighted-Average Grant-Date Fair Value
Non-vested at January 1, 2024 |  | 763,212 |  |  | $ | 27.45 |
Granted |  | 613,534 |  |  | 25.00 |
Forfeited/Canceled |  | (78,272) |  |  | 26.71 |
Vested |  | (340,952) |  |  | 28.78 |
Non-vested at December 31, 2024 |  | 957,522 |  |  | $ | 25.47 |
A summary of the status of the Company’s non-vested RSUs as of December 31, 2024, and changes during the year then ended, is presented below:
|  | Restricted Award Units |  | Weighted-Average Grant-Date Fair Value
Non-vested at January 1, 2024 |  | 383,701 |  |  | $ | 29.31 |
Granted |  | 260,999 |  |  | 25.75 |
Forfeited/Canceled |  | (40,208) |  |  | 31.00 |
Vested |  | (82,966) |  |  | 36.52 |
Non-vested at December 31, 2024 |  | 521,526 |  |  | $ | 26.25 |
Schedule of Restricted Stock and Restricted Stock Units Activity | Information regarding restricted stock awards during each of the following years is presented below:
|  | For the Year Ended December 31,
|  | 2024 |  | 2023 |  | 2022
Weighted-average grant date fair value |  | $ | 25.00 |  |  | $ | 24.57 |  |  | $ | 33.08 |
Fair value of awards vested 1 |  | $ | 9,813 |  |  | $ | 8,156 |  |  | $ | 6,923 |
1 Based on grant date fair value, in thousands.
Information regarding restricted stock units during each of the following years is presented below:
|  | For the Year Ended December 31,
|  | 2024 |  | 2023 |  | 2022
Weighted-average grant date fair value |  | $ | 25.75 |  |  | $ | 22.84 |  |  | $ | 34.11 |
Fair value of awards vested 1 |  | $ | 3,030 |  |  | $ | 1,997 |  |  | $ | 2,305 |
1 Based on grant date fair value, in thousands.
Schedule of Stock Option Valuation Assumptions |
|  | For the Year Ended December 31,
|  | 2024 |  | 2023 |  | 2022
Risk-free interest rates |  | N/A |  | 4.25 | % |  | 2.21 | %
Expected dividend yield |  | N/A |  | 2.45 | % |  | 1.95 | %
Expected volatility |  | N/A |  | 64.32 | % |  | 32.09 | %
Expected lives (years) |  | N/A |  | 1.8 |  | 1.0
Schedule of Stock Options Roll Forward | A summary of the Company’s stock options as of December 31, 2024, and changes during the year then ended, is presented below:
|  | Options |  | Weighted-Average Exercise Price
Outstanding at January 1, 2024 |  | 823,963 |  |  | $ | 20.48 |
Granted |  | — |  |  | — |
Exercised |  | (185,606) |  |  | 13.31 |
Expired |  | (17,715) |  |  | 30.04 |
Outstanding and Exercisable at December 31, 2024 |  | 620,642 |  |  | $ | 22.38 |
Weighted-Average Remaining Contractual Term (Years) |  | 2.70 |  |
Aggregate Intrinsic Value (000s) |  | $ | 3,933 |  |  |
Schedule of Stock Option Activity | The following table presents information related to stock options during each of the following years:
|  | For the Year Ended December 31,
|  | 2024 |  | 2023 |  | 2022
Weighted-average grant date fair value |  | N/A |  | $ | 12.63 |  |  | $ | 14.28 |
Intrinsic value of stock options exercised, in thousands |  | $ | 2,487 |  |  | 5,969 |  |  | 8,860 |
Schedule of Employee Stock Purchase Plan Activity |
|  | 2024 |  | 2023 |  | 2022
ESPP shares purchased |  | 32,840 |  |  | 35,630 |  |  | 20,972 |
Weighted-average employee purchase price |  | $ | 24.42 |  |  | $ | 22.56 |  |  | $ | 30.76 |

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the changes in outstanding nonvested shares. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of employee stock purchase plan activity. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year. + References No definition available. + Details
Name: | us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the change in stock options. + References No definition available. + Details
Name: | us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of cost not yet recognized and weighted-average period over which cost is expected to be recognized for nonvested award under share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (i) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration